RK
Robert C Koski
Director

Robert C Koski insider trades: Oragenics (OGEN) stock buys and sales

Director, Oragenics Last trade Dec 30, 2022 425 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
339
Open-market trades
since 2005
6
Companies
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Robert reports to the SEC

Open-market buys and sales

339 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 30, 2022OGEN↓ Sell$4K
Dec 29, 2022OGEN↓ Sell$4K
Dec 15, 2022OGEN↓ Sell$29K
Dec 14, 2022OGEN↓ Sell$788
Dec 9, 2022OGEN↓ Sell$10K
Dec 8, 2022OGEN↓ Sell$3K
Nov 30, 2022OGEN↓ Sell$77K
Dec 31, 2021OGEN↑ Buy$469K
Dec 22, 2020OGEN↓ Sell$132K
Dec 30, 2019OGEN↓ Sell$104K
Jul 31, 2019HLIO↓ Sell$152K
Jul 24, 2019HLIO↓ Sell$240K
Jun 27, 2019HLIO↓ Sell$111K
Jun 24, 2019HLIO↓ Sell$114K
Jun 21, 2019HLIO↓ Sell$235K
Jun 18, 2019HLIO↓ Sell$114K
Jun 17, 2019HLIO↓ Sell$1.2M
Jun 14, 2019SNHY↓ Sell$306K
Jun 7, 2019SNHY↓ Sell$113K
Mar 29, 2019SNHY↓ Sell$465K
Mar 4, 2019SNHY↓ Sell$249K
Sep 21, 2018SNHY↓ Sell$1.7M
Sep 19, 2018SNHY↓ Sell$1.1M
Sep 18, 2018OGEN↑ Buy$71K
Sep 17, 2018SNHY↓ Sell$997K
Sep 13, 2018SNHY↓ Sell$800K
Sep 10, 2018SNHY↓ Sell$1.2M
Sep 6, 2018SNHY↓ Sell$376K
May 30, 2018SNHY↓ Sell$495K
May 30, 2018SNHY↓ Sell$1.8M
May 17, 2018SNHY↓ Sell$1.2M
Jan 26, 2018LKAI↑ Buy$22K
Sep 6, 2017SNHY↓ Sell$748K
Aug 15, 2017SNHY↓ Sell$778K
Aug 11, 2017SNHY↓ Sell$904K
Aug 9, 2017SNHY↓ Sell$947K
Jun 2, 2017SNHY↓ Sell$220K
Jun 1, 2017SNHY↓ Sell$1.0M
May 25, 2017SNHY↓ Sell$244K
May 23, 2017SNHY↓ Sell$844K
May 15, 2017SNHY↓ Sell$420K
May 12, 2017SNHY↓ Sell$1.3M
May 9, 2017SNHY↓ Sell$2.5M
May 5, 2017SNHY↓ Sell$800K
May 2, 2017SNHY↓ Sell$1.6M
Mar 31, 2017SNHY↓ Sell$181K
Oct 5, 2016SNHY↓ Sell$1.5M
Aug 29, 2016SNHY↓ Sell$576K
Aug 24, 2016SNHY↓ Sell$988K
Jun 30, 2016OGEN.BC↑ Buy$3.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other OGEN insiders

Open-market trades in the last 12 months

About Robert C Koski's insider trades

Robert C Koski is a director at Oragenics (OGEN). Since May 27, 2005, Robert has reported 26 open-market purchases worth $15.0M and 313 sales worth $135.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (80 filings), gifts (16 filings), other transactions (7 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OGEN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.